Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heart rate variability--a therapeutic target?

H C Routledge1, S Chowdhary, J N Townend

  • 1Division of Medical Sciences (Cardiology), Queen Elizabeth Hospital, Birmingham, UK. h.routledge@bham.ac.uk

Journal of Clinical Pharmacy and Therapeutics
|April 27, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cochlear implantation in a profoundly deaf child with cystic leukoencephalopathy without megalencephaly.

The Journal of laryngology and otology·2022
Same author

Quantification of biomaterial dispersion during otologic procedures and role of barrier drapes in Covid 2019 era - a laboratory model.

The Journal of laryngology and otology·2020
Same author

VAD and CHIPS please.

International journal of cardiology·2019
Same author

Premature coronary artery disease and early stage chronic kidney disease.

QJM : monthly journal of the Association of Physicians·2017
Same author

Re: assessment of myocardial fibrosis with T1 mapping MRI.

Clinical radiology·2016
Same author

Variability in cardiac MR measurement of left ventricular ejection fraction, volumes and mass in healthy adults: defining a significant change at 1 year.

The British journal of radiology·2015

Reduced heart rate variability (HRV), an indicator of cardiac vagal control, predicts poor prognosis. Augmenting cardiac vagal control may reduce mortality, suggesting HRV as a potential therapeutic target.

Area of Science:

  • Cardiology
  • Autonomic Nervous System Function

Background:

  • Reduced heart rate variability (HRV) is a significant predictor of adverse outcomes in cardiac patients and the general population.
  • HRV reflects vagally mediated beat-to-beat variability, primarily indicating cardiac vagal control.

Purpose of the Study:

  • To explore the relationship between cardiac vagal control and mortality.
  • To discuss the potential mechanisms by which cardiac vagal activity influences prognosis.
  • To review the use of HRV as a therapeutic target and predictor of clinical efficacy.

Main Methods:

  • Review of existing literature on HRV, cardiac vagal control, and mortality.
  • Analysis of animal studies on augmenting cardiac vagal control and its effect on sudden death.
  • Examination of human studies on drugs that reduce mortality and increase HRV.

Related Experiment Videos

Main Results:

  • Augmenting cardiac vagal control in animals reduces sudden death.
  • Several drugs proven to reduce mortality and sudden death in humans also increase HRV.
  • The relationship between cardiac vagal control and mortality requires further investigation to determine causality.

Conclusions:

  • Cardiac vagal activity may beneficially influence prognosis through mechanisms like reduced myocardial oxygen demand and decreased susceptibility to lethal arrhythmias.
  • The observed association between increased HRV and reduced mortality with certain drugs suggests HRV could be a surrogate marker for therapeutic efficacy.
  • Further research is needed to establish a causative link and fully explore HRV as a therapeutic target.